Group 1: Super League Enterprise, Inc. - Super League Enterprise, Inc. announced a $10 million strategic equity investment from Evo Fund, leading to a sharp increase in its stock price [1] - Shares of Super League Enterprise rose 200% to $9.83 in pre-market trading following the announcement [1] Group 2: Other Notable Gainers - Professional Diversity Network, Inc. gained 88.8% to $5.40 in pre-market trading after a previous rise of around 4% [4] - STRATA Skin Sciences, Inc. rose 80% to $3.06 in pre-market trading after an 8% increase on Monday [4] - Jiuzi Holdings, Inc. jumped 50.9% to $1.69 in pre-market trading after a 5% gain on Monday [4] - New Era Energy & Digital, Inc. gained 47.2% to $0.8941 in pre-market trading after a surge of around 12% on Monday [4] - Better Home & Finance Holding Company increased by 30% to $64.95 in pre-market trading, following a 46% jump on Monday [4] - MicroCloud Hologram Inc. surged 29% to $7.17 in pre-market trading after announcing a breakthrough in quantum technology [4] - Cassava Sciences, Inc. rose 24.1% to $2.88 in pre-market trading after CEO Richard Barry purchased shares at an average price of $2.25 [4] - SES AI Corporation surged 10.3% to $2.04 in pre-market trading after a 17% increase on Monday [4] - Ballard Power Systems Inc. gained 8.3% to $3.12 in pre-market trading after a 5% rise on Monday [4] Group 3: Notable Decliners - Psyence Biomedical Ltd. dipped 19.6% to $3.65 in pre-market trading after a decline of around 5% on Monday [4] - Diginex Limited shares fell 17.7% to $14.60 in pre-market trading after a jump of over 30% on Monday [4] - Addentax Group Corp. declined 16.5% to $0.9021 in pre-market trading after gaining more than 30% on Monday [4] - Boxlight Corporation fell 15.5% to $4.03 in pre-market trading after a significant jump of 205% on Monday [4] - Reliance Global Group, Inc. dropped 15.5% to $0.9122 in pre-market trading after a 47% increase on Monday [4] - Qualigen Therapeutics, Inc. declined 14.1% to $4.75 in pre-market trading after a 95% jump on Monday [4] - Fly-E Group, Inc. fell 13.1% to $0.8773 in pre-market trading after announcing a securities purchase agreement [4] - Firefly Aerospace Inc. dropped 12.5% to $43.29 in pre-market trading after reporting a second-quarter loss [4] - Opendoor Technologies Inc. dipped 6.3% to $7.85 in pre-market trading after a 12% fall on Monday [4] - Symbotic Inc. fell 4.8% to $57.80 in pre-market trading after a gain of more than 6% on Monday [4]

Company Acquisitions - Pfizer Inc. has agreed to acquire Metsera, Inc. to enhance its portfolio in medicines targeting obesity and cardiometabolic diseases, introducing a range of oral and injectable therapy candidates [2] Stock Market Performance - U.S. stocks showed a mostly positive trend, with the Nasdaq Composite gaining over 50 points, while the Dow increased by 0.01% to 46,321.12, and the S&P 500 rose by 0.15% to 6,674.60 [1] - Information technology shares increased by 0.4%, while consumer staples stocks fell by 0.5% [1] Commodity Market - Oil prices decreased by 0.7% to $62.23, while gold prices increased by 1.3% to $3,752.30. Silver rose by 2.1% to $43.835, and copper fell by 0.4% to $4.6085 [5] Stock Movements - AgriFORCE Growing Systems Ltd. saw a significant increase of 157% to $6.20 following its announcement to rename and raise approximately $550 million [9] - Qualigen Therapeutics, Inc. surged by 141% to $6.86 after a $41 million investment from Faraday Future [9] - MBX Biosciences, Inc. rose by 134% to $23.43 after positive trial results for its product [9] - Chijet Motor Company, Inc. shares dropped by 38% to $0.1813 following the appointment of a new COO [9] - Cosan S.A. shares fell by 23% to $4.3850 after a downgrade from HSBC [9] - Quantum Computing Inc. experienced a decline of 14% to $19.97 after announcing a $500 million private placement [9]

Group 1 - Faraday Future (FFAI.US) shares declined over 8%, trading at $1.625 [1] - The company announced a $41 million investment in Qualigen Therapeutics (QLGN.US) to support its entry into the crypto and Web3 sectors [1] - Following the investment announcement, Qualigen Therapeutics' stock surged over 95%, reaching $5.55 [1] Group 2 - The investment will provide Faraday Future with significant equity in Qualigen and plans to appoint a management team to lead new business activities [1]

Core Viewpoint - Faraday Future (FFAI.US) stock price declined over 8% to $1.625 following the announcement of a $41 million investment in Qualigen Therapeutics (QLGN.US) to support its entry into the crypto and Web3 sectors [1] Group 1: Company Actions - Faraday Future announced a $41 million investment in Qualigen Therapeutics to facilitate its expansion into the crypto and Web3 markets [1] - This investment will provide Faraday Future with significant equity in Qualigen and plans to appoint a management team to lead new business activities [1] Group 2: Market Reactions - Following the investment announcement, Qualigen Therapeutics' stock surged over 95%, reaching $5.55 [1]

Core Viewpoint - Faraday Future (FFAI.US) stock price declined over 8% to $1.625 following the announcement of a $41 million investment in Qualigen Therapeutics (QLGN.US) to support its entry into the crypto and Web3 sectors [1] Group 1 - Faraday Future's investment in Qualigen Therapeutics amounts to $41 million [1] - Following the investment announcement, Qualigen Therapeutics' stock surged over 95% to $5.55 [1] - The investment will provide Faraday Future with significant equity in Qualigen and plans to assign a management team to lead new business activities [1]

Market Overview - U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points, down 0.25% to 46,201.74, while the NASDAQ rose 0.05% to 22,642.88 and the S&P 500 dropped 0.07% to 6,659.98 [1] - European shares were mostly lower, with the eurozone's STOXX 600 falling 0.3%, Spain's IBEX 35 Index down 1.1%, London's FTSE 100 up 0.1%, Germany's DAX 40 down 0.7%, and France's CAC 40 down 0.5% [5] - Asian markets closed mixed, with Japan's Nikkei gaining 0.99%, Hong Kong's Hang Seng dipping 0.76%, China's Shanghai Composite rising 0.22%, and India's BSE Sensex falling 0.56% [6] Sector Performance - Consumer discretionary shares increased by 0.2% on Monday, while energy stocks fell by 0.6% [1] Commodity Prices - Oil traded down 0.6% to $62.28, while gold rose 1.3% to $3,755.20. Silver increased by 1.9% to $43.780, and copper fell 0.2% to $4.6170 [4] Company News - AgriFORCE Growing Systems Ltd. shares surged 220% to $7.70 after announcing a name change to AVAX One and plans to raise approximately $550 million [9] - Qualigen Therapeutics, Inc. shares rose 152% to $7.16 following a $41 million investment from Faraday Future [9] - MBX Biosciences, Inc. shares increased by 140% to $24.00 after reporting that its Canvuparatide achieved primary endpoint in a Phase 2 trial [9] - Chijet Motor Company, Inc. shares dropped 32% to $0.1970 after naming Jason Miller as COO [9] - AtlasClear Holdings, Inc. shares fell 30% to $0.6401, and AlphaVest Acquisition Corp shares decreased by 27% to $16.16 [9]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - AgriFORCE Growing Systems Ltd. (AGRI) has increased by 263% to $8.73 [3] - Qualigen Therapeutics, Inc. (QLGN) has risen by 212% to $8.87 [3] - Flora Growth Corp. (FLGC) is up 103% at $55.36 [3] - Boxlight Corporation (BOXL) has gained 102% to $3.16 [3] - Platinum Analytics Cayman Limited (PLTS) is up 96% at $14.00 [3] - Metsera, Inc. (MTSR) has increased by 59% to $52.99 [3] - Anywhere Real Estate Inc. (HOUS) is up 51% at $10.72 [3] - Fold Holdings, Inc. (FLD) has risen by 30% to $5.93 [3] - ARB IOT Group Limited (ARBB) is up 28% at $8.02 [3] - MBX Biosciences, Inc. (MBX) has increased by 26% to $12.64 [3] Premarket Losers - AlphaVest Acquisition Corp (ATMV) has decreased by 27% to $15.99 [4] - Helius Medical Technologies, Inc. (HSDT) is down 17% at $20.00 [4] - CEA Industries Inc. (BNC) has fallen by 15% to $8.20 [4] - Simpple Ltd. (SPPL) is down 13% at $5.00 [4] - FatPipe, Inc. (FATN) has decreased by 11% to $7.87 [4] - Tharimmune, Inc. (THAR) is down 11% at $3.20 [4] - Yueda Digital Holding (YDKG) has fallen by 11% to $2.98 [4] - American Battery Technology Company (ABAT) is down 10% at $2.94 [4] - AGM Group Holdings Inc. (AGMH) has decreased by 9% to $9.36 [4] - Antelope Enterprise Holdings Limited (AEHL) is down 5% at $3.38 [4]

Core Viewpoint - Qualigen Therapeutics has entered into a PIPE agreement with Faraday Future, involving a financing of approximately $41 million, aimed at transitioning the company towards cryptocurrency and Web3-related businesses [4][6]. Financing Details - The financing round is led by Faraday Future and its CEO Jia Yueting, with a total investment of about $41 million, including $30 million from Faraday Future at a price of $2.246 per share, giving it a 55% ownership stake in Qualigen [4][6]. - Jia Yueting plans to invest an additional $4 million personally, acquiring about 7% of Qualigen's common stock [4][6]. Strategic Shift - Following the investment, Qualigen is expected to rebrand as CXC10 and focus on cryptocurrency and Web3, moving away from its current biopharmaceutical operations, which are struggling [6][10]. - The company aims to create a new business model centered around a crypto ecosystem, decentralized AI trading, and value stabilization [6][10]. Company Background - Qualigen has faced significant challenges, including a risk of delisting from NASDAQ due to its stock price falling below $1 for 30 consecutive days [8][9]. - Recent leadership changes occurred as the previous CEO and CFO resigned due to strategic disagreements, leading to the appointment of new executives with experience in turning around small-cap companies [9][10]. Current Operations - Qualigen's core product pipeline focuses on rare cancer treatments, with ongoing projects like QN-302 in Phase 1 trials and Pan-RAS in lead optimization [10]. - Despite the strategic investment, the company has not shown substantial operational improvements, and its future remains uncertain in the highly competitive biopharmaceutical industry [10].

Core Viewpoint - Qualigen Therapeutics has entered into a PIPE agreement with Faraday Future, involving a $41 million investment focused on cryptocurrency and Web3 business planning [2][4] Group 1: Investment Details - The financing amount is approximately $41 million, led by Faraday Future and its CEO Jia Yueting, with participation from other investors including the SIGN Foundation [2] - Faraday Future will invest about $30 million in Qualigen at a price of $2.246 per share, acquiring approximately 55% of the common stock [2] - Jia Yueting plans to invest around $4 million personally, corresponding to about 7% of Qualigen's common stock [2] Group 2: Strategic Shift - Following the investment, Qualigen is expected to rebrand as CXC10 and shift its focus towards cryptocurrency and Web3, moving away from its current biopharmaceutical operations [4] - The new business model will emphasize a "three-horsepower" strategy involving Crypto, a decentralized AI trading exchange, and a value stabilizer [4] - After the investment, Faraday Future and Jia Yueting will collectively hold 62% of Qualigen's shares, with plans for management involvement [4] Group 3: Company Background and Challenges - Qualigen has faced significant challenges, including a risk of delisting from NASDAQ due to stock price issues, with a recent notification received for failing to meet minimum price requirements [6][7] - The company has experienced leadership changes, with recent resignations of key executives due to strategic disagreements [6][7] - Qualigen's core product pipeline is focused on rare cancer treatments, but progress has been slow, with key projects still in early development stages [7][8]

Core Viewpoint - Faraday Future Intelligent Electric Inc. is strategically investing approximately $30 million in Qualigen Therapeutics, Inc. to initiate a crypto and web3-related business, aiming to enhance its dual-flywheel and dual-bridge eco strategy to maximize shareholder value [1][2][8] Investment Details - The total investment in Qualigen Therapeutics will be around $41 million, with Faraday Future contributing about $30 million for approximately 55% of QLGN's common stock on a pro forma basis [2][3] - YT Jia, Founder & Global Co-CEO, will invest $4 million and receive about 7% of QLGN's common stock, with a two-year lockup on his shares [3][4] Management and Governance - Faraday Future plans to assign management teams to oversee relevant business activities, with YT Jia serving as chief advisor to QLGN and Jerry Wang expected to be appointed as Co-CEO [4] - Following the investment, Faraday Future will have the right to nominate two of five directors on QLGN's board, which could increase to four of seven if stockholder approval is obtained [4] Rebranding and Product Focus - Qualigen Therapeutics is expected to rebrand as CXC10, focusing on three growth engines in the crypto ecosystem, including the C10 Treasury, BesTrade DeAI Agent, and ecosystem tokens [5][6][7] - The C10 Treasury has shown an unrealized gain of around 7%, outperforming the C10 index, with a 20% actively managed allocation yielding positive results [9] Product Innovations - The FX Super One MPV was showcased at the annual 919 event, featuring an ultra-wide dual-screen panoramic display and advanced EAI OS for enhanced user interaction [10][12][13] - The EAI Space in the FX Super One is designed to provide a personalized and immersive experience, integrating hardware, software, and applications for seamless user engagement [15][16][17] Future Outlook - Faraday Future aims to bridge Web2 and Web3, as well as AI and crypto, positioning itself as a leading U.S. public company in the evolving digital landscape [6][9]